Navigation Links
New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin
Date:7/8/2008

DALLAS July 8, 2008 An analysis of more than 100 patients has confirmed for the first time that darker-skinned patients benefit as those with lighter skin when given light therapy for morphea and related diseases, UT Southwestern Medical Center researchers show.

Phototherapy is the use of ultraviolet light to treat skin disorders, ranging from common problems such as acne and psoriasis to rarer conditions such as scleroderma and morphea, a hardening of the skin.

Some clinical observations have suggested that darker skin may not respond as well to light therapy, but the new data indicate that skin type does not significantly influence the effectiveness of UVA1 phototherapy, said Dr. Heidi Jacobe, assistant professor of dermatology at UT Southwestern and lead author of the study appearing in the June edition of the British Journal of Dermatology.

"This study is good news, indicating that UVA1 phototherapy should be considered as a therapeutic option for more darkly pigmented patients," noted Dr. Jacobe, who heads UT Southwestern's phototherapy clinic, one of a select few UVA1 phototherapy units in the Southwest.

Patients with diseases such as morphea respond better when treated earlier in the course of the disease, so it's important to know whether a particular treatment such as light therapy is useful.

Researchers reviewed 101 cases treated at UT Southwestern's phototherapy clinic over a three-year period ending in 2007, noting demographic and diagnostic data, skin type and clinical outcome, using standard improvement scales.

Researchers noted that the cumulative dose used did not vary significantly between skin types, and there was little or no correlation between skin type and clinical improvement scores.

The majority of patients treated at the center were diagnosed with either morphea or scleroderma. The maladies often cause discolorations of the thickened skin, usually red or purple
'/>"/>

Contact: Russell Rian
russell.rian@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Ivy Foundation Funds New Brain Cancer Research Consortium : $3M Stage I Project Aims to Improve Personalized Medicine for Patients
2. The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary
3. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
4. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
5. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
6. Inaugural Big Expedition for Cancer Research Encounters Mountain As Challenging As Finding a Cure for Cancer
7. American Parkinson Disease Association Awards More Than $3.7 Million to Research
8. Stanford researchers find molecule that kills kidney cancer cells
9. TonerForAutism.com Strives to Fund Autism Research Through Online Sales
10. Signalife and Heart One Global Research Agree to Merge
11. Pioneering stroke researcher awarded Canadas highest honor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New research reveals ultraviolet light therapy is as beneficial for darker skin as lighter skin
(Date:9/3/2015)... ... September 03, 2015 , ... ... to Watch for 2015 by economic development group GrowFL and the Edward ... in the state selected for this prestigious award, which recognizes growing second-stage companies ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, ... of her debut book, “Stop Wasting Your Time Blaming Others for Your Life.” ... Hartley’s guide to overcoming life’s obstacles by taking full responsibility for one’s life ...
(Date:9/3/2015)... ... September 03, 2015 , ... For the second year ... Inc. 5000 list of fastest-growing private companies in America. President and Editor-in-Chief ... nation's companies have demonstrated such remarkably consistent high growth, particularly in the difficult ...
(Date:9/3/2015)... ... , ... According to an Oncology Nurse Advisor article published on ... oropharyngeal cancer (oral cancer) to be successfully diagnosed and treated for relapses of the ... which have a high rate of success in treatment and elimination of the disease; ...
(Date:9/3/2015)... ... September 03, 2015 , ... DiabetesSisters Welcomes ... to announce the additional of Carol Wysham, MD, to their esteemed Board of ... Karczmarczyk, Donna Rice, David Warren, Matt Stella, Tricia Cedotal, Andrea Thomas, Wanda Nicholson ...
Breaking Medicine News(10 mins):Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 2Health News:IQ Formulations Hailed Among Florida Companies to Watch for 2015 3Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2
... After a major review of scientific information, six leading ... nicotine reduction strategy should be an urgent research priority ... and disease from tobacco use. Their findings were ... According to this new report, reducing the amount ...
... YORK, October 1, 2010--A multi-institutional team led by investigators ... that provides new insight into genetic changes that make ... primary brain cancer, more aggressive than others and explains ... research was led by senior author Eric C. Holland, ...
... By Amanda Gardner HealthDay Reporter , THURSDAY, ... with ovarian cancer relapse who start chemotherapy as soon as ... significantly longer than women who wait until symptoms begin to ... often precede the reappearance of symptoms in an ovarian cancer ...
... research published in the October edition of the ... the use of chemotherapy in a contemporary, diverse non-small ... Prior population-based studies have shown that only 20 to ... treatment. These studies have previously relied on the Medicare-linked ...
... conducted by University of California, San Diego researchers 14 years ... come with just enough sleep. Less than five hours a ... much. A team of scientists, headed by Daniel F. ... School of Medicine, revisited original research conducted between 1995 and ...
... Ky. The University of Louisville School of Nursing has ... Health and Human Services Health Resources and Services Administration ... graduate nursing students as well as practicing nurses from ... be able to process a tsunami of patient data ...
Cached Medicine News:Health News:Experts urge making cigarettes non-addictive a research priority 2Health News:Researchers discover genetic changes that make some forms of brain cancer more aggressive 2Health News:New Clues to Treating Ovarian Cancer Relapse 2Health News:New Clues to Treating Ovarian Cancer Relapse 3Health News:New lung cancer research finds half of advanced lung cancer patients receive chemotherapy 2Health News:Women's study finds longevity means getting just enough sleep 2Health News:UofL School of Nursing awarded grant to fund new informatics education project 2
(Date:9/3/2015)... , Sept. 3, 2015  The findings of a ... disturbing questions about the company,s handling of its ... On September 2 nd , part one of ... events, including at least 27 fatalities, have been associated ... confidential study commissioned by C.R. Bard in 2004 which ...
(Date:9/3/2015)... , Sept. 3, 2015 Research and Markets ... "Investigation Report on China Olmesartan Market, 2010-2019" ... olmesartan medoxomil was successfully developed by Sankyo Pharmaceuticals Co., ... 2002, olmesartan medoxomil was approved by FDA to enter ... the best- selling drug in the world after it ...
(Date:9/3/2015)... Sept. 3, 2015 Research and Markets ... the "Investigation Report on China Tamsulosin Market, ... Compared with other a1- adrenergic receptor blockers, ... and lower risk of urinary tract infections and ... its debut in 1993 in Japan ...
Breaking Medicine Technology:IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 2IVC Filter Lawsuit News: NBC News Investigation into C.R. Bard Recovery Filters Raises Disturbing Questions, Bernstein Liebhard LLP Reports 3China Olmesartan Investigation Market Report 2010-2019 2China Tamsulosin Market Investigation Report 2015 2
... SHENZHEN, China , July 20 /PRNewswire-Asia-FirstCall/ ... developer, manufacturer and,marketer of medical devices worldwide, today announced that it ... 30, 2010 after the U.S.,market closes on August 9, ... 8:00 AM on August 10, 2010 U.S. Eastern ...
... SHELTON, Conn. , July 20 HealthPlanOne, a general ... increase staffing for Medicare Solutions during the 2011 Annual Enrollment Period ... has been significantly compressed by health reform legislation. , ... Historically, Medicare recipients could select ...
Cached Medicine Technology:Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010 2Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010 3Seniors Shortchanged on Time as Annual Enrollment Period Shrinks This Fall 2
Inquire...
Inquire...
... The Tourneau Eyewear Collection was inspired by the ... accessories. It will be appreciated by all men ... 65. The collection incorporates a complete range of ... a retro-flare take advantage of the best that ...
... The collection features a range of ... most modern materials and producted to ... collection includes several super lightweight Titanium ... as a whole host of beautifully ...
Medicine Products: